Quantcast
Last updated on April 23, 2014 at 12:54 EDT

Latest Complete Genomics Inc. Stories

2013-07-18 16:25:39

Parties agree to dismiss all claims and counterclaims in two lawsuits brought by Illumina. No payments or license grants are being made by either party. MOUNTAIN VIEW, Calif., July 18, 2013 /PRNewswire/ -- Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), a wholly-owned subsidiary of BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that it has entered into a settlement agreement with Illumina, Inc. under which...

2013-03-18 16:24:25

Combined Company to Focus on High Volume, Accurate Human Genomic Sequencing and Accelerating the Spread of Genomic Medicine SHENZHEN, China and MOUNTAIN VIEW, Calif., March 18, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has successfully completed the acquisition of Complete Genomics, Inc. (formerly NASDAQ: GNOM)...

2013-02-26 00:21:47

SHENZHEN, China and MOUNTAIN VIEW, Calif., Feb. 25, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the Ministry of Commerce of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete. BGI and Complete are awaiting...

2013-02-01 20:21:08

SHENZHEN, China, Feb. 1, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 12:00 midnight (New York City time) on Wednesday, February 6, 2013. The Offer was previously scheduled to expire at 12:00 midnight (New York City time) on Friday, February 1,...

2013-01-11 20:22:15

SHENZHEN, China and MOUNTAIN VIEW, Calif., Jan. 11, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the National Development and Reform Commission of the People's Republic of China regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete. BGI's...

2013-01-11 20:22:13

SHENZHEN, China, Jan. 11, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 12:00 midnight (New York City time) on Friday, January 18, 2013. The Offer was previously scheduled to expire at 12:00 midnight (New York City time) on Friday,...

2012-12-29 00:20:16

SHENZHEN, China and MOUNTAIN VIEW, Calif., Dec. 28, 2012 /PRNewswire/ -- BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the Committee on Foreign Investment in the United States ("CFIUS") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete. BGI's financial...

2012-12-29 00:20:14

SHENZHEN, China, Dec. 28, 2012 /PRNewswire/ -- BGI-Shenzhen ("BGI") announced today that it, through its wholly owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 12:00 am ET on Monday, January 7, 2013. The Offer was previously scheduled to expire at 12:00 am ET on Monday, December 31, 2012. Except for the extension of the Offer...

2012-12-13 20:21:34

SHENZHEN, China, Dec. 13, 2012 /PRNewswire/ -- BGI-Shenzhen ("BGI") announced today that it, through its wholly owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 12:00 midnight (New York City time) on Monday, December 31, 2012. The Offer was previously scheduled to expire at 12:00 midnight (New York City time) on Friday, December 14,...

2012-10-22 19:21:13

SHENZHEN, China, Oct. 22, 2012 /PRNewswire/ -- BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 12:00 midnight (New York City time) on Wednesday, November 21, 2012. The Offer was previously scheduled to expire at 12:00 midnight (New York City time) on Tuesday, October 23,...